Other News To Note
Wednesday, November 7, 2012
Compugen Ltd., of Tel Aviv, Israel, reported the discovery and initial validation of two additional cancer targets for its monoclonal antibody therapy.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.